News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
87,486 Results
Type
Article (2739)
Company Profile (64)
Press Release (84683)
Section
Business (32671)
Career Advice (69)
Deals (6100)
Drug Delivery (8)
Drug Development (9215)
Employer Resources (9)
FDA (1605)
Job Trends (2264)
News (47715)
Policy (2757)
Tag
Academia (182)
Accelerated approval (4)
Allergies (25)
Alliances (3251)
ALS (14)
Alzheimer's disease (200)
Antibody-drug conjugate (ADC) (42)
Approvals (1686)
Artificial intelligence (35)
Autoimmune disease (20)
Automation (2)
Bankruptcy (24)
Best Places to Work (2017)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (35)
Bladder cancer (22)
Brain cancer (4)
Breast cancer (108)
Cancer (646)
Cardiovascular disease (54)
Career advice (65)
CAR-T (19)
CDC (3)
Cell therapy (60)
Cervical cancer (10)
Clinical research (8430)
Collaboration (112)
Company closure (1)
Compensation (72)
Complete response letters (1)
COVID-19 (280)
CRISPR (6)
C-suite (32)
Cystic fibrosis (12)
Data (930)
Depression (10)
Diabetes (45)
Diagnostics (897)
Digital health (4)
Diversity, equity & inclusion (3)
Drug discovery (12)
Drug pricing (10)
Drug shortages (4)
Duchenne muscular dystrophy (17)
Earnings (28819)
Editorial (3)
Employer branding (2)
Employer resources (10)
Events (10090)
Executive appointments (30)
FDA (2138)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (10)
Funding (132)
Gene editing (15)
Generative AI (5)
Gene therapy (37)
GLP-1 (109)
Government (340)
Grass and pollen (2)
Guidances (267)
Healthcare (2499)
HIV (13)
Huntington's disease (1)
IgA nephropathy (12)
Immunology and inflammation (30)
Immuno-oncology (9)
Indications (14)
Infectious disease (300)
Inflammatory bowel disease (12)
Influenza (10)
Intellectual property (10)
Interviews (6)
IPO (4511)
IRA (2)
Job creations (322)
Job search strategy (57)
JPM (4)
Kidney cancer (4)
Labor market (13)
Layoffs (57)
Leadership (1)
Legal (467)
Liver cancer (9)
Lung cancer (113)
Lymphoma (65)
Machine learning (2)
Management (3)
Manufacturing (70)
MASH (21)
Medical device (1859)
Medtech (1867)
Mergers & acquisitions (1781)
Metabolic disorders (129)
Multiple sclerosis (43)
NASH (2)
Neurodegenerative disease (36)
Neuropsychiatric disorders (14)
Neuroscience (347)
Neurotech (1)
NextGen: Class of 2026 (646)
Non-profit (367)
Now hiring (2)
Obesity (65)
Opinion (9)
Ovarian cancer (29)
Pain (13)
Pancreatic cancer (27)
Parkinson's disease (23)
Partnered (1)
Patents (18)
Patient recruitment (25)
Peanut (13)
People (2584)
Pharmaceutical (12)
Pharmacy benefit managers (6)
Phase 1 (2008)
Phase 2 (3364)
Phase 3 (3678)
Pipeline (1503)
Policy (16)
Postmarket research (384)
Preclinical (652)
Press Release (5)
Prostate cancer (16)
Radiopharmaceuticals (41)
Rare diseases (68)
Real estate (407)
Recruiting (3)
Regulatory (2392)
Reports (12)
Research institute (189)
Resumes & cover letters (6)
Rett syndrome (3)
RSV (8)
Schizophrenia (21)
Series A (14)
Series B (13)
Service/supplier (5)
Sickle cell disease (9)
Special edition (4)
Spinal muscular atrophy (18)
Sponsored (4)
Startups (211)
Stomach cancer (1)
Supply chain (17)
Tariffs (25)
The Weekly (3)
Vaccines (91)
Venture capital (9)
Weight loss (41)
Women's health (8)
Worklife (4)
Date
Today (16)
Last 7 days (69)
Last 30 days (227)
Last 365 days (4779)
2026 (308)
2025 (4828)
2024 (5410)
2023 (6159)
2022 (9174)
2021 (10100)
2020 (9093)
2019 (5594)
2018 (4305)
2017 (3798)
2016 (3061)
2015 (4203)
2014 (2863)
2013 (2039)
2012 (1976)
2011 (2236)
2010 (1890)
Location
Africa (56)
Alabama (5)
Alaska (1)
Arizona (24)
Asia (4306)
Australia (479)
California (1599)
Canada (587)
China (126)
Colorado (104)
Connecticut (66)
Delaware (70)
Europe (11938)
Florida (247)
Georgia (63)
Idaho (3)
Illinois (109)
India (6)
Indiana (101)
Japan (77)
Kansas (23)
Kentucky (4)
Louisiana (8)
Maine (20)
Maryland (202)
Massachusetts (1189)
Michigan (47)
Minnesota (105)
Missouri (22)
Montana (5)
Nevada (13)
New Hampshire (10)
New Jersey (597)
New Mexico (2)
New York (444)
North Carolina (192)
North Dakota (2)
Northern California (883)
Ohio (44)
Oregon (2)
Pennsylvania (324)
Rhode Island (8)
South America (172)
Southern California (589)
Tennessee (16)
Texas (241)
United States (5948)
Utah (44)
Virginia (20)
Washington D.C. (7)
Washington State (119)
Wisconsin (15)
87,486 Results for "55".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Think Bioscience Raises $55M in Oversubscribed Series A
January 21, 2026
·
2 min read
Obesity
Lilly Doubles Down With Nimbus, Paying $55M for Preclinical Obesity Drug
Eli Lilly kicked off a pivotal 2026 campaign with a multi-year collaboration with current partner Nimbus Therapeutics worth a potential $1.3 billion for a preclinical obesity therapeutic. The deal follows a 2022 partnership struck by the companies to target the AMPK protein in cardiometabolic diseases.
January 6, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Oncology API Market Set for a Powerful Leap Towards USD 69.55 Billion Revenue
December 5, 2025
·
1 min read
Neuroscience
Roche Piles $55M Into Blood-Brain Barrier Tech With Manifold
Manifold will use its tissue-targeting shuttle technology to help Roche develop new therapeutics for diseases of the central nervous system.
November 3, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Bioxodes raises €5.5 million Series A extension to continue preparations for pivotal trial of breakthrough stroke candidate
December 10, 2025
·
5 min read
Press Releases
Aeovian Pharmaceuticals Raises $55 Million to Advance First-in-Class Selective mTORC1 Inhibitor for Tuberous Sclerosis Complex-Related Epilepsy
December 17, 2025
·
4 min read
Press Releases
4TEEN4 Extends Series C Financing Round to €55 Million, Supporting Expanded Clinical Development of Procizumab in Cardiogenic Shock
November 13, 2025
·
4 min read
Press Releases
Anti-Obesity Drug Market Outlook 2025–2032: Strong CAGR of 18.01% with USD 82.55 Billion Valuation
October 17, 2025
·
1 min read
Press Releases
Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim
September 23, 2025
·
3 min read
Manufacturing
J&J To Add 500 Jobs at New Plant, Doubling Down on North Carolina
Johnson & Johnson’s second facility in Wilson, North Carolina, is part of a $55 billion push to make all advanced medicines used in the U.S. domestically.
January 13, 2026
·
2 min read
·
Nick Paul Taylor
1 of 8,749
Next
